APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oseltamivir Phosphate Antiviral Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oseltamivir Phosphate Antiviral Drug Market Outlook and Growth Opportunities 2026

21 December 2025209 pages

Choose your research edition.

Industry ResearchOseltamivir Phosphate Antiviral Drug Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Oseltamivir Phosphate Antiviral Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Oseltamivir Phosphate Antiviral Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oseltamivir Phosphate Antiviral Drug Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Oseltamivir Phosphate Antiviral Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Oseltamivir Phosphate Antiviral Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oseltamivir Phosphate Antiviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oseltamivir Phosphate Antiviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oseltamivir Phosphate Antiviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oseltamivir Phosphate Antiviral Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oseltamivir Phosphate Antiviral Drug market include Teva Pharmaceuticals, SL Pharmaceutica, Cspc Holdings, Roche Group, Kelun Pharmaceutical, HEC ChangJiang Pharmaceutical, BrightGene Bio-Medical Technology, Zydus Cadila and Strides Pharma Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oseltamivir Phosphate Antiviral Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oseltamivir Phosphate Antiviral Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oseltamivir Phosphate Antiviral Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oseltamivir Phosphate Antiviral Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Oseltamivir Phosphate Antiviral Drug Segment by Company

Teva Pharmaceuticals

SL Pharmaceutica

Cspc Holdings

Roche Group

Kelun Pharmaceutical

HEC ChangJiang Pharmaceutical

BrightGene Bio-Medical Technology

Zydus Cadila

Strides Pharma Inc.

Novadoz

Natco Pharma

Macleods Pharmaceuticals

LUPINE Limited

Hetero Group

Camber Pharmaceuticals

Amneal Pharmaceuticals

Alvogen

Alembic Pharmaceuticals

Ajanta Pharma

Oseltamivir Phosphate Antiviral Drug Segment by Type

Capsule

Suspension

Oseltamivir Phosphate Antiviral Drug Segment by Application

Child

Aldult

Oseltamivir Phosphate Antiviral Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oseltamivir Phosphate Antiviral Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oseltamivir Phosphate Antiviral Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oseltamivir Phosphate Antiviral Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Oseltamivir Phosphate Antiviral Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oseltamivir Phosphate Antiviral Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oseltamivir Phosphate Antiviral Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oseltamivir Phosphate Antiviral Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oseltamivir Phosphate Antiviral Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oseltamivir Phosphate Antiviral Drug industry.

Chapter 3: Detailed analysis of Oseltamivir Phosphate Antiviral Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oseltamivir Phosphate Antiviral Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oseltamivir Phosphate Antiviral Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oseltamivir Phosphate Antiviral Drug Industry Trends Table 2. Oseltamivir Phosphate Antiviral Drug Industry Drivers Table 3. Oseltamivir Phosphate Antiviral Drug Industry Opportunities and Challenges Table 4. Oseltamivir Phosphate Antiviral Drug Industry Restraints Table 5. Global Oseltamivir Phosphate Antiviral Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oseltamivir Phosphate Antiviral Drug Revenue Share by Company (2021-2026) Table 7. Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Company (k units) & (2021-2026) Table 8. Global Oseltamivir Phosphate Antiviral Drug Sales Volume Share by Company (2021-2026) Table 9. Global Oseltamivir Phosphate Antiviral Drug Average Price (US$/unit) of Company (2021-2026) Table 10. Global Oseltamivir Phosphate Antiviral Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oseltamivir Phosphate Antiviral Drug Key Company Manufacturing Base & Headquarters Table 12. Global Oseltamivir Phosphate Antiviral Drug Company, Product Type & Application Table 13. Global Oseltamivir Phosphate Antiviral Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oseltamivir Phosphate Antiviral Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Capsule Table 18. Significant Companies of Suspension Table 19. Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Type (2021-2026) & (k units) Table 21. Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Type (2027-2032) & (k units) Table 22. Global Oseltamivir Phosphate Antiviral Drug Sales Volume Share by Type (2021-2026) Table 23. Global Oseltamivir Phosphate Antiviral Drug Sales Volume Share by Type (2027-2032) Table 24. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type (2021-2026) Table 28. Global Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Child Table 30. Significant Companies of Aldult Table 31. Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Application (2021-2026) & (k units) Table 33. Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Application (2027-2032) & (k units) Table 34. Global Oseltamivir Phosphate Antiviral Drug Sales Volume Share by Application (2021-2026) Table 35. Global Oseltamivir Phosphate Antiviral Drug Sales Volume Share by Application (2027-2032) Table 36. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application (2021-2026) Table 40. Global Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application (2027-2032) Table 41. Global Oseltamivir Phosphate Antiviral Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2021-2026) & (k units) Table 43. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Region (2021-2026) Table 44. Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2027-2032) & (k units) Table 45. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Region (2027-2032) Table 46. Global Oseltamivir Phosphate Antiviral Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Oseltamivir Phosphate Antiviral Drug Sales Value Share by Region (2021-2026) Table 49. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Oseltamivir Phosphate Antiviral Drug Sales Value Share by Region (2027-2032) Table 51. Global Oseltamivir Phosphate Antiviral Drug Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Oseltamivir Phosphate Antiviral Drug Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Oseltamivir Phosphate Antiviral Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 56. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2021-2026) Table 57. Global Oseltamivir Phosphate Antiviral Drug Sales by Country (2027-2032) & (k units) Table 58. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2027-2032) Table 59. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Oseltamivir Phosphate Antiviral Drug Sales Value Market Share by Country (2021-2026) Table 61. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Oseltamivir Phosphate Antiviral Drug Sales Value Market Share by Country (2027-2032) Table 63. Teva Pharmaceuticals Company Information Table 64. Teva Pharmaceuticals Business Overview Table 65. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 67. Teva Pharmaceuticals Recent Development Table 68. SL Pharmaceutica Company Information Table 69. SL Pharmaceutica Business Overview Table 70. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 72. SL Pharmaceutica Recent Development Table 73. Cspc Holdings Company Information Table 74. Cspc Holdings Business Overview Table 75. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 77. Cspc Holdings Recent Development Table 78. Roche Group Company Information Table 79. Roche Group Business Overview Table 80. Roche Group Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Roche Group Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 82. Roche Group Recent Development Table 83. Kelun Pharmaceutical Company Information Table 84. Kelun Pharmaceutical Business Overview Table 85. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 87. Kelun Pharmaceutical Recent Development Table 88. HEC ChangJiang Pharmaceutical Company Information Table 89. HEC ChangJiang Pharmaceutical Business Overview Table 90. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 92. HEC ChangJiang Pharmaceutical Recent Development Table 93. BrightGene Bio-Medical Technology Company Information Table 94. BrightGene Bio-Medical Technology Business Overview Table 95. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 97. BrightGene Bio-Medical Technology Recent Development Table 98. Zydus Cadila Company Information Table 99. Zydus Cadila Business Overview Table 100. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 102. Zydus Cadila Recent Development Table 103. Strides Pharma Inc. Company Information Table 104. Strides Pharma Inc. Business Overview Table 105. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 107. Strides Pharma Inc. Recent Development Table 108. Novadoz Company Information Table 109. Novadoz Business Overview Table 110. Novadoz Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Novadoz Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 112. Novadoz Recent Development Table 113. Natco Pharma Company Information Table 114. Natco Pharma Business Overview Table 115. Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Natco Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 117. Natco Pharma Recent Development Table 118. Macleods Pharmaceuticals Company Information Table 119. Macleods Pharmaceuticals Business Overview Table 120. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 122. Macleods Pharmaceuticals Recent Development Table 123. LUPINE Limited Company Information Table 124. LUPINE Limited Business Overview Table 125. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 127. LUPINE Limited Recent Development Table 128. Hetero Group Company Information Table 129. Hetero Group Business Overview Table 130. Hetero Group Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Hetero Group Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 132. Hetero Group Recent Development Table 133. Camber Pharmaceuticals Company Information Table 134. Camber Pharmaceuticals Business Overview Table 135. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 137. Camber Pharmaceuticals Recent Development Table 138. Amneal Pharmaceuticals Company Information Table 139. Amneal Pharmaceuticals Business Overview Table 140. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 142. Amneal Pharmaceuticals Recent Development Table 143. Alvogen Company Information Table 144. Alvogen Business Overview Table 145. Alvogen Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Alvogen Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 147. Alvogen Recent Development Table 148. Alembic Pharmaceuticals Company Information Table 149. Alembic Pharmaceuticals Business Overview Table 150. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 151. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 152. Alembic Pharmaceuticals Recent Development Table 153. Ajanta Pharma Company Information Table 154. Ajanta Pharma Business Overview Table 155. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 156. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 157. Ajanta Pharma Recent Development Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Oseltamivir Phosphate Antiviral Drug Distributors List Table 161. Oseltamivir Phosphate Antiviral Drug Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Oseltamivir Phosphate Antiviral Drug Product Image Figure 2. Global Oseltamivir Phosphate Antiviral Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oseltamivir Phosphate Antiviral Drug Sales (2021-2032) & (k units) Figure 5. Global Oseltamivir Phosphate Antiviral Drug Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Oseltamivir Phosphate Antiviral Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Capsule Image Figure 10. Suspension Image Figure 11. Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Oseltamivir Phosphate Antiviral Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Oseltamivir Phosphate Antiviral Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Oseltamivir Phosphate Antiviral Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type (2021-2032) Figure 17. Child Image Figure 18. Aldult Image Figure 19. Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Oseltamivir Phosphate Antiviral Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Oseltamivir Phosphate Antiviral Drug Sales Volume Share by Application (2021-2032) Figure 22. Global Oseltamivir Phosphate Antiviral Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Oseltamivir Phosphate Antiviral Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application (2021-2032) Figure 25. Global Oseltamivir Phosphate Antiviral Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Oseltamivir Phosphate Antiviral Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Oseltamivir Phosphate Antiviral Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032) & (US$ Million) Figure 30. North America Oseltamivir Phosphate Antiviral Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Oseltamivir Phosphate Antiviral Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032) & (US$ Million) Figure 36. South America Oseltamivir Phosphate Antiviral Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Oseltamivir Phosphate Antiviral Drug Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Oseltamivir Phosphate Antiviral Drug Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Suspension
Applications
  • Child
  • Aldult
Companies covered
  • Teva Pharmaceuticals
  • SL Pharmaceutica
  • Cspc Holdings
  • Roche Group
  • Kelun Pharmaceutical
  • HEC ChangJiang Pharmaceutical
  • BrightGene Bio-Medical Technology
  • Zydus Cadila
  • Strides Pharma Inc.
  • Novadoz
  • Natco Pharma
  • Macleods Pharmaceuticals
  • LUPINE Limited
  • Hetero Group
  • Camber Pharmaceuticals
  • Amneal Pharmaceuticals
  • Alvogen
  • Alembic Pharmaceuticals
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032)
  4. 1.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Oseltamivir Phosphate Antiviral Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oseltamivir Phosphate Antiviral Drug Market Dynamics
  1. 2.1 Oseltamivir Phosphate Antiviral Drug Industry Trends
  2. 2.2 Oseltamivir Phosphate Antiviral Drug Industry Drivers
  3. 2.3 Oseltamivir Phosphate Antiviral Drug Industry Opportunities and Challenges
  4. 2.4 Oseltamivir Phosphate Antiviral Drug Industry Restraints
3 Oseltamivir Phosphate Antiviral Drug Market by Company
  1. 3.1 Global Oseltamivir Phosphate Antiviral Drug Company Revenue Ranking in 2025
  2. 3.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Company (2021-2026)
  3. 3.3 Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Oseltamivir Phosphate Antiviral Drug Average Price by Company (2021-2026)
  5. 3.5 Global Oseltamivir Phosphate Antiviral Drug Company Ranking (2024-2026)
  6. 3.6 Global Oseltamivir Phosphate Antiviral Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Oseltamivir Phosphate Antiviral Drug Company Product Type and Application
  8. 3.8 Global Oseltamivir Phosphate Antiviral Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oseltamivir Phosphate Antiviral Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oseltamivir Phosphate Antiviral Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oseltamivir Phosphate Antiviral Drug Market by Type
  1. 4.1 Oseltamivir Phosphate Antiviral Drug Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Suspension
  4. 4.2 Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Type
  5. 4.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Oseltamivir Phosphate Antiviral Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Type
  9. 4.3.1 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type (2021-2032)
5 Oseltamivir Phosphate Antiviral Drug Market by Application
  1. 5.1 Oseltamivir Phosphate Antiviral Drug Application Introduction
  2. 5.1.1 Child
  3. 5.1.2 Aldult
  4. 5.2 Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Application
  5. 5.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Oseltamivir Phosphate Antiviral Drug Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Application
  9. 5.3.1 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Application (2021-2032)
  11. 5.3.3 Global Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application (2021-2032)
6 Oseltamivir Phosphate Antiviral Drug Regional Sales and Value Analysis
  1. 6.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2027-2032)
  5. 6.3 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Oseltamivir Phosphate Antiviral Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032)
  12. 6.6.2 North America Oseltamivir Phosphate Antiviral Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Oseltamivir Phosphate Antiviral Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032)
  21. 6.9.2 South America Oseltamivir Phosphate Antiviral Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Value Share by Country, 2025 VS 2032
7 Oseltamivir Phosphate Antiviral Drug Country-level Sales and Value Analysis
  1. 7.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Country (2027-2032)
  6. 7.4 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oseltamivir Phosphate Antiviral Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oseltamivir Phosphate Antiviral Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oseltamivir Phosphate Antiviral Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oseltamivir Phosphate Antiviral Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 SL Pharmaceutica
  8. 8.2.1 SL Pharmaceutica Company Information
  9. 8.2.2 SL Pharmaceutica Business Overview
  10. 8.2.3 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product Portfolio
  12. 8.2.5 SL Pharmaceutica Recent Developments
  13. 8.3 Cspc Holdings
  14. 8.3.1 Cspc Holdings Company Information
  15. 8.3.2 Cspc Holdings Business Overview
  16. 8.3.3 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product Portfolio
  18. 8.3.5 Cspc Holdings Recent Developments
  19. 8.4 Roche Group
  20. 8.4.1 Roche Group Company Information
  21. 8.4.2 Roche Group Business Overview
  22. 8.4.3 Roche Group Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roche Group Oseltamivir Phosphate Antiviral Drug Product Portfolio
  24. 8.4.5 Roche Group Recent Developments
  25. 8.5 Kelun Pharmaceutical
  26. 8.5.1 Kelun Pharmaceutical Company Information
  27. 8.5.2 Kelun Pharmaceutical Business Overview
  28. 8.5.3 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio
  30. 8.5.5 Kelun Pharmaceutical Recent Developments
  31. 8.6 HEC ChangJiang Pharmaceutical
  32. 8.6.1 HEC ChangJiang Pharmaceutical Company Information
  33. 8.6.2 HEC ChangJiang Pharmaceutical Business Overview
  34. 8.6.3 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio
  36. 8.6.5 HEC ChangJiang Pharmaceutical Recent Developments
  37. 8.7 BrightGene Bio-Medical Technology
  38. 8.7.1 BrightGene Bio-Medical Technology Company Information
  39. 8.7.2 BrightGene Bio-Medical Technology Business Overview
  40. 8.7.3 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product Portfolio
  42. 8.7.5 BrightGene Bio-Medical Technology Recent Developments
  43. 8.8 Zydus Cadila
  44. 8.8.1 Zydus Cadila Company Information
  45. 8.8.2 Zydus Cadila Business Overview
  46. 8.8.3 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product Portfolio
  48. 8.8.5 Zydus Cadila Recent Developments
  49. 8.9 Strides Pharma Inc.
  50. 8.9.1 Strides Pharma Inc. Company Information
  51. 8.9.2 Strides Pharma Inc. Business Overview
  52. 8.9.3 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product Portfolio
  54. 8.9.5 Strides Pharma Inc. Recent Developments
  55. 8.10 Novadoz
  56. 8.10.1 Novadoz Company Information
  57. 8.10.2 Novadoz Business Overview
  58. 8.10.3 Novadoz Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novadoz Oseltamivir Phosphate Antiviral Drug Product Portfolio
  60. 8.10.5 Novadoz Recent Developments
  61. 8.11 Natco Pharma
  62. 8.11.1 Natco Pharma Company Information
  63. 8.11.2 Natco Pharma Business Overview
  64. 8.11.3 Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Natco Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio
  66. 8.11.5 Natco Pharma Recent Developments
  67. 8.12 Macleods Pharmaceuticals
  68. 8.12.1 Macleods Pharmaceuticals Company Information
  69. 8.12.2 Macleods Pharmaceuticals Business Overview
  70. 8.12.3 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  72. 8.12.5 Macleods Pharmaceuticals Recent Developments
  73. 8.13 LUPINE Limited
  74. 8.13.1 LUPINE Limited Company Information
  75. 8.13.2 LUPINE Limited Business Overview
  76. 8.13.3 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product Portfolio
  78. 8.13.5 LUPINE Limited Recent Developments
  79. 8.14 Hetero Group
  80. 8.14.1 Hetero Group Company Information
  81. 8.14.2 Hetero Group Business Overview
  82. 8.14.3 Hetero Group Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Hetero Group Oseltamivir Phosphate Antiviral Drug Product Portfolio
  84. 8.14.5 Hetero Group Recent Developments
  85. 8.15 Camber Pharmaceuticals
  86. 8.15.1 Camber Pharmaceuticals Company Information
  87. 8.15.2 Camber Pharmaceuticals Business Overview
  88. 8.15.3 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  90. 8.15.5 Camber Pharmaceuticals Recent Developments
  91. 8.16 Amneal Pharmaceuticals
  92. 8.16.1 Amneal Pharmaceuticals Company Information
  93. 8.16.2 Amneal Pharmaceuticals Business Overview
  94. 8.16.3 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  96. 8.16.5 Amneal Pharmaceuticals Recent Developments
  97. 8.17 Alvogen
  98. 8.17.1 Alvogen Company Information
  99. 8.17.2 Alvogen Business Overview
  100. 8.17.3 Alvogen Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Alvogen Oseltamivir Phosphate Antiviral Drug Product Portfolio
  102. 8.17.5 Alvogen Recent Developments
  103. 8.18 Alembic Pharmaceuticals
  104. 8.18.1 Alembic Pharmaceuticals Company Information
  105. 8.18.2 Alembic Pharmaceuticals Business Overview
  106. 8.18.3 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  108. 8.18.5 Alembic Pharmaceuticals Recent Developments
  109. 8.19 Ajanta Pharma
  110. 8.19.1 Ajanta Pharma Company Information
  111. 8.19.2 Ajanta Pharma Business Overview
  112. 8.19.3 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio
  114. 8.19.5 Ajanta Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oseltamivir Phosphate Antiviral Drug Value Chain Analysis
  2. 9.1.1 Oseltamivir Phosphate Antiviral Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oseltamivir Phosphate Antiviral Drug Sales Mode & Process
  6. 9.2 Oseltamivir Phosphate Antiviral Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oseltamivir Phosphate Antiviral Drug Distributors
  9. 9.2.3 Oseltamivir Phosphate Antiviral Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst